We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Pursuing dynamics of minimal residual leukemic subclones in relapsed and refractory acute myeloid leukemia during conventional therapy.
- Authors
Kim, Dongchan; Kim, Sheehyun; Song, Hyojin; Gwak, Daehyeon; Min, Suji; Byun, Ja Min; Koh, Youngil; Hong, Junshik; Yoon, Sung‐Soo; Yun, Hongseok; Shin, Dong‐Yeop
- Abstract
Background: Acute myeloid leukemia (AML) is characterized by clonal heterogeneity, leading to frequent relapses and drug resistance despite intensive clinical therapy. Although AML's clonal architecture has been addressed in many studies, practical monitoring of dynamic changes in those subclones during relapse and treatment is still understudied. Method: Fifteen longitudinal bone marrow (BM) samples were collected from three relapsed and refractory (R/R) AML patients. Using droplet digital polymerase chain reaction (ddPCR), the frequencies of patient's leukemic variants were assessed in seven cell populations that were isolated from each BM sample based on cellular phenotypes. By quantifying mutant clones at the diagnosis, remission, and relapse stages, the distribution of AML subclones was sequentially monitored. Results: Minimal residual (MR) leukemic subclones exhibit heterogeneous distribution among BM cell populations, including mature leukocyte populations. During AML progression, these subclones undergo active phenotypic transitions and repopulate into distinct cell population regardless of normal hematopoiesis hierarchic order. Of these, MR subclones in progenitor populations of patient BM predominantly carry MR leukemic properties, leading to more robust expansion and stubborn persistence than those in mature populations. Moreover, a minor subset of MR leukemic subclones could be sustained at an extremely low frequency without clonal expansion during relapse. Conclusions: In this study, we observed treatment persistent MR leukemic subclones and their phenotypic changes during the treatment process of R/R AML patients. This underscores the importance of preemptive inhibition of clonal promiscuity in R/R AML, proposing a practical method for monitoring AML MR subclones.
- Subjects
ACUTE myeloid leukemia; PHENOTYPIC plasticity; POLYMERASE chain reaction; PRELEUKEMIA; SUBSTANCE abuse relapse; CELL populations
- Publication
Cancer Medicine, 2024, Vol 13, Issue 7, p1
- ISSN
2045-7634
- Publication type
Article
- DOI
10.1002/cam4.7182